pH-Responsive Lipid Assemblies for Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current non-viral gene delivery systems, such as cationic liposomes, face challenges with colloidal stability and toxicity, and while amphoteric liposomes offer improved tolerance, they lag behind viral systems in transfection efficacy and immune response issues.
Innovation Solution
Development of lipids with transfection enhancer elements (TEEs) that undergo a pH-sensitive hydrophile-hydrophobe transition, enhancing fusogenicity with cell membranes, and their incorporation into lipid assemblies like liposomes to improve cellular uptake and delivery of nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cationic liposomes are used for gene delivery, then transfection efficiency is improved, but colloidal stability deteriorates and toxicity increases
Solution Approach 1:
The patent applies parameter changes by modifying the charge state of liposomes as a function of pH. The liposomes are designed to be cationic at acidic pH (enhancing transfection efficiency) and anionic at physiological pH (improving colloidal stability and reducing toxicity). This dynamic parameter change allows the system to optimize performance at different stages of the delivery process.
Solution Approach 2:
The invention implements dynamics through pH-responsive charge switching. The liposome charge is not fixed but dynamically changes in response to pH variations encountered during circulation and cellular uptake. This dynamic adaptation enables the system to maintain stability in blood (anionic at pH 7.4) while becoming fusogenic at endosomal pH (cationic at acidic conditions).
2Productivity
If cationic liposomes are used for gene delivery, then transfection efficiency is improved, but toxicity increases
Solution Approach 1:
The patent applies parameter changes by modifying the charge state of liposomes as a function of pH. The liposomes are designed to be cationic at acidic pH (enhancing transfection efficiency) and anionic at physiological pH (improving colloidal stability and reducing toxicity). This dynamic parameter change allows the system to optimize performance at different stages of the delivery process.
Solution Approach 2:
The invention implements dynamics through pH-responsive charge switching. The liposome charge is not fixed but dynamically changes in response to pH variations encountered during circulation and cellular uptake. This dynamic adaptation enables the system to maintain stability in blood (anionic at pH 7.4) while becoming fusogenic at endosomal pH (cationic at acidic conditions).
3Object-affected harmful factors
If amphoteric liposomes are used for gene delivery, then safety and tolerance are improved, but transfection efficacy deteriorates
Solution Approach 1:
The patent applies dynamics through pH-responsive charge switching. The liposome charge is not fixed but dynamically changes in response to pH variations encountered during circulation and cellular uptake. This dynamic adaptation enables the system to maintain stability in blood (anionic at pH 7.4) while becoming fusogenic at endosomal pH (cationic at acidic conditions).
Solution Approach 2:
The invention utilizes phase transitions in the form of charge state transitions driven by pH changes. The liposomes undergo a charge phase transition from anionic to cationic as they move from physiological pH to acidic endosomal pH, enabling them to switch between stable circulation and active membrane fusion states.
4Productivity
If viral vectors are used for gene delivery, then transfection efficacy is improved, but immune response increases
Solution Approach 1:
The patent applies the extraction principle by removing the viral components that trigger immune responses while retaining and enhancing the essential fusogenic function. The invention uses synthetic pH-responsive lipids that mimic the pH-dependent membrane fusion capability of viral envelopes without containing viral genetic material or surface proteins, thereby eliminating immunogenicity while maintaining transfection efficacy.
Solution Approach 2:
The invention employs synthetic, non-viral lipid structures that can be designed for single-use delivery without the long-term persistence and immune recognition associated with viral vectors. These synthetic liposomes provide the necessary fusogenic function temporarily during delivery then are metabolized without triggering sustained immune responses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pH-sensitive lipids enhance the fusogenicity and cellular uptake of liposomes, improving the delivery of nucleic acids and reducing toxicity, offering a safer and more effective non-viral gene delivery method compared to existing systems.
Implementation Method 1
The TEE comprises a hydrophobic moiety and a pH sensitive hydrophilic moiety which responds to a pH drop from physiological pH to low pH by a hydrophile-hydrophobe transition
Implementation Method 2
the pH sensitive hydrophilic moiety of each TEE is independently a weak acid having pKa of between 2 and 6
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Lipid assemblies, such as liposomes, comprising transfection enhancer elements (TEE's), which are complexed with the lipid assemblies by means of ionic interactions, or lipids incorporating such TEE's are disclosed for enhancing the fusogenicity of the lipid assemblies. The TEE's have the formula: hydrophobic moiety - pH sensitive hydrophilic moiety (II) The pH sensitive hydrophilic moiety of each TEE is a weak acid having a pka of between 2 and 6 or a zwitterionic structure comprising a combination of acidic groups with weak bases having a pKa of between 3 and 8. Lipids incorporating one or more such TEEs have the formula (I): Lipid moiety- [Hydrophobic moiety - pH sensitive hydrophilic moiety] (I).